Milestone Pharmaceuticals (MIST) EPS (Basic) Growth (1y) (2019 - 2022)
Milestone Pharmaceuticals (MIST) EPS (Basic) Growth (1y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | -16.29% |
| 10 | Milestone Pharmaceuticals | 43.32 Mn | -128.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -4.90% |
| Jun 30, 2022 | -2,251.35% |
| Dec 31, 2021 | -36.67% |
| Sep 30, 2021 | 16.19% |
| Jun 30, 2021 | 103.51% |
| Mar 31, 2021 | 54.44% |
| Dec 31, 2020 | 74.51% |
| Sep 30, 2020 | 23.21% |
| Jun 30, 2020 | 49.10% |
| Mar 31, 2020 | 96.16% |
| Dec 31, 2019 | 96.19% |
| Sep 30, 2019 | 97.40% |
| Jun 30, 2019 | 91.85% |
| Mar 31, 2019 | -11.32% |